Articles

• Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraineA multicenter, double-blind, placebo-controlled, dose range-finding study

  A. M. Rapoport, N. M. Ramadan, J. U. Adelman, N. T. Mathew, A. H. Elkind, D. B. Kudrow, N. L. Earl, The 017 Clinical Trial Study Group†

  • Abstract
  • Full Text
  • Full Text (PDF)
• Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine

  G. D. Solomon, R. K. Cady, J. A. Klapper, N. L. Earl, J. R. Saper, N. M. Ramadan, The 042 Clinical Trial Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Sumatriptan nasal spray for the acute treatment of migraineResults of two clinical studies

  R. Ryan, A. Elkind, C. C. Baker, W. Mullican, S. DeBussey, M. Asgharnejad

  • Abstract
  • Full Text
  • Full Text (PDF)
• A new locus for hemiplegic migraine maps to chromosome 1q31

  Kathy Gardner, M. Michael Barmada, Louis J. Ptacek, Eric P. Hoffman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Spinocerebellar ataxia type 6Molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion

  R. Matsumura, N. Futamura, Y. Fujimoto, S. Yanagimoto, H. Horikawa, A. Suzumura, T. Takayanagi

  • Abstract
  • Full Text
  • Full Text (PDF)
• Clinical and molecular features of spinocerebellar ataxia type 6

  G. Stevanin, A. Dürr, G. David, O. Didierjean, G. Cancel, S. Rivaud, A. Tourbah, J.-M. Warter, Y. Agid, A. Brice

  • Abstract
  • Full Text
  • Full Text (PDF)
• Spinocerebellar ataxia type 6Frequency of the mutation and genotype-phenotype correlations

  D. H. Geschwind, S. Perlman, K. P. Figueroa, J. Karrim, R. W. Baloh, S. M. Pulst

  • Abstract
  • Full Text
  • Full Text (PDF)
• Gene locus FPD1 of the dystonic Mount-Reback type of autosomal-dominant paroxysmal choreoathetosis

  K. Hofele, R. Benecke, G. Auburger

  • Abstract
  • Full Text
  • Full Text (PDF)
• Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control

  S. Shimoda-Matsubayashi, T. Hattori, H. Matsumine, A. Shinohara, A. Yoritaka, H. Mori, T. Kondo, M. Chiba, Y. Mizuno

  • Abstract
  • Full Text
  • Full Text (PDF)
• Olfactory dysfunction in familial parkinsonism

  K. Markopoulou, K. W. Larsen, E. K. Wszolek, M. A. Denson, A. E. Lang, R. F. Pfeiffer, Z. K. Wszolek

  • Abstract
  • Full Text
  • Full Text (PDF)
• Smoking and Parkinson's diseaseAn age-dependent risk effect?

  C. Tzourio, W. A. Rocca, M. M. Breteler, M. Baldereschi, J.-F. Dartigues, S. Lopez-Pousa, J.-M. Manubens-Bertran, A. Alpérovitch, the EUROPARKINSON Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease [RETRACTED]

  Yoshihiro Sato, Munetsugu Kikuyama, Kotaro Oizumi

  • Abstract
  • Full Text (PDF)
• Stereotactic pallidotomy lengthens the transcranial magnetic cortical stimulation silent period in Parkinson's disease

  M. S. Young, W. J. Triggs, D. Bowers, M. Greer, W. A. Friedman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990

  James H. Bower, Demetrius M. Maraganore, Shannon K. McDonnell, Walter A. Rocca

  • Abstract
  • Full Text
  • Full Text (PDF)
• Multifocal motor neuropathySerum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates

  Alan Pestronk, Rati Choksi

  • Abstract
  • Full Text
  • Full Text (PDF)
• Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosisEvidence from paired transcranial magnetic stimulation

  Ulf Ziemann, Martin Winter, Carl D. Reimers, Karin Reimers, Frithjof Tergau, Walter Paulus

  • Abstract
  • Full Text
  • Full Text (PDF)
• Autosomal dominant progressive syndrome of motor-speech loss without dementia

  Sandra Bond Chapman, Roger N. Rosenberg, Myron F. Weiner, Angela Shobe

  • Abstract
  • Full Text
  • Full Text (PDF)
• Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjectsA retrospective postmortem immunocytochemical and histofluorescent study

  John Heitner, Dennis Dickson

  • Abstract
  • Full Text
  • Full Text (PDF)
• Neurophysiologic correlates of implicit face memory in intracranial visual evoked potentials

  M. Seeck, N. Mainwaring, R. Cosgrove, H. Blume, D. Dubuisson, M.-M. Mesulam, D. L. Schomer

  • Abstract
  • Full Text
  • Full Text (PDF)
• Anosognosia and confabulation during the Wada test

  L. H. Lu, A. M. Barrett, R. L. Schwartz, J. E. Cibula, R. L. Gilmore, B. M. Uthman, K. M. Heilman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Hereditary endotheliopathy with retinopathy, nephropathy, and stroke(HERNS)

  J. Jen, A. H. Cohen, Q. Yue, J. T. Stout, H. V. Vinters, S. Nelson, R. W. Baloh

  • Abstract
  • Full Text
  • Full Text (PDF)
• The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct

  K. Majamaa, J. Turkka, M. Kärppä, S. Winqvist, I. E. Hassinen

  • Abstract
  • Full Text
  • Full Text (PDF)
• Acute stroke: Prognosis and a prediction of the effect of medical treatment on outcome and health care utilizationThe Copenhagen Stroke Study

  Henrik Stig Jørgensen, Hirofumi Nakayama, Hans Otto Raaschou, Tom Skyhøj Olsen

  • Abstract
  • Full Text
  • Full Text (PDF)
• Clinical profiles predictive of outcome in pontine hemorrhage

  Eelco F.M. Wijdicks, Erik St. Louis

  • Abstract
  • Full Text
  • Full Text (PDF)
• Basilar artery embolismClinical syndrome and neuroradiologic patterns in patients without permanent occlusion of the basilar artery

  Stefan Schwarz, Thomas Egelhof, Stefan Schwab, Werner Hacke

  • Abstract
  • Full Text
  • Full Text (PDF)
• I. Impaired dark adaptation in symptomatic carotid artery disease

  Ult Havelius, David Bergqvist, Pia Falke, Bengt Hindfelt, Torsten Krakau

  • Abstract
  • Full Text
  • Full Text (PDF)
• II. Improved dark adaptation after carotid endarterectomyEvidence of a long-term ischemic penumbra?

  Ulf Havelius, David Bergqvist, Bengt Hindfelt, Torsten Krakau

  • Abstract
  • Full Text
  • Full Text (PDF)
• Motor deficits and optokinetic stimulation in patients with left hemineglect

  Giuseppe Vallar, Cecilia Guariglia, Daniele Nico, Luigi Pizzamiglio

  • Abstract
  • Full Text
  • Full Text (PDF)
• Sensorimotor cerebral activation during optokinetic nystagmusA functional MRI study

  Stefan F. Bucher, Marianne Dieterich, Klaus C. Seelos, Thomas Brandt

  • Abstract
  • Full Text
  • Full Text (PDF)
• Clinical-pathologic correlation in a patient with selective loss of hair cells in the vestibular endorgans

  R. W. Baloh, I. Lopez, K. Beykirch, A. Ishiyama, V. Honrubia

  • Abstract
  • Full Text
  • Full Text (PDF)
• Congenital porencephaly and hippocampal sclerosisClinical features and epileptic spectrum

  S. S. Ho, R. I. Kuzniecky, F. Gilliam, E. Faught, M. Bebin, R. Morawetz

  • Abstract
  • Full Text
  • Full Text (PDF)
• Electroconvulsive therapy for treatment of intractable seizuresInitial findings in two children

  David A. Griesemer, Charles H. Kellner, Mark D. Beale, Georgette M. Smith

  • Abstract
  • Full Text
  • Full Text (PDF)
• Adult-onset Krabbe disease with homozygous T1853C mutation in the galactocerebrosidase gene

  J.-I. Satoh, H. Tokumoto, K. Kurohara, M. Yukitake, M. Matsui, Y. Kuroda, T. Yamamoto, H. Furuya, N. Shinnoh, T. Kobayashi, Y. Kukita, K. Hayashi

  • Abstract
  • Full Text
  • Full Text (PDF)
• Delayed posthypoxic demyelinationAssociation with arylsulfatase A deficiency and lactic acidosis on proton MR spectroscopy

  Jay A. Gottfried, Stephan A. Mayer, Dikoma C. Shungu, Yuan Chang, Jozef H. Duyn

  • Abstract
  • Full Text
  • Full Text (PDF)
• The 5-year risk of MS after optic neuritisExperience of the Optic Neuritis Treatment Trial

  Optic Neuritis Study Group*

  • Abstract
  • Full Text
  • Full Text (PDF)
• Risk factors for developing multiple sclerosis after childhood optic neuritis

  C. F. Lucchinetti, L. Kiers, A. O'Duffy, M. R. Gomez, S. Cross, J. A. Leavitt, P. O'Brien, M. Rodriguez

  • Abstract
  • Full Text
  • Full Text (PDF)
• The measurement of ambulatory impairment in multiple sclerosis

  S. R. Schwid, A. D. Goodman, D. H. Mattson, C. Mihai, K. M. Donohoe, M. D. Petrie, E. A. Scheid, J. T. Dudman, M. P. McDermott

  • Abstract
  • Full Text
  • Full Text (PDF)
• Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease

  S. Barz, T. Hummel, E. Pauli, M. Majer, C. J. G. Lang, G. Kobal

  • Abstract
  • Full Text
  • Full Text (PDF)